SecBot SecBot

PMHS

Polomar Health Services, Inc.
OTC· Pharmaceutical Preparations· Inc. NV· CIK 0001265521 Biotech & Drug Discovery
$0.1500 +0.02 (+15.38%)
Oct 26 4:00 PM ET · prev $0.1300
1 year
−25.0%
from $0.2000 · Oct 28
30 days
−11.8%
from $0.1700
52-week range
$0.0650–0.7999
−81% from high · low Jul 30
Avg volume 20D
13.0K
Oct 6 spike 48.8K
Short interest
940
−81.0%
Days to cover
1.0
at average volume
Filing reports
4
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 1/2
Strongest NEUTRAL Two directors, Alexandra Peterson and Gabrielle Toledano, resigned from the board of Polomar Health…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • Short sellersCOVERING

    Short interest −81.0% to 940 shares. 1.0 days to cover.

  • TrendDOWNTREND

    20% below its 50-day average.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 19, 2026 SEC
Two directors, Alexandra Peterson and Gabrielle Toledano, resigned from the board of Polomar Health Services…
8-K — Impact 3/10
Sep 24, 2026 SEC
Polomar Health Services, Inc. (PMHS) received SEC effectiveness on September 23, 2026, for its shelf registration…
EFFECT — Impact 3/10
May 15, 2026 SEC
Polomar Health Services and Altanine waived five key closing conditions for their merger, including the S-4…
8-K — Impact 6/10

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Aug 31, 2026
940
shares short
-81.0%
vs prior settlement
1.0
days to cover

SecBot reports

4 filings · 0 bullish · 1 bearish · 1 mixed · 2 neutral
All PMHS filing & press-release reports (4)